Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endogenous DPD substrate ratios and 5-FU pharmacokinetics/toxicity study
NL-OMON21471Not yet recruiting
- Sponsor
- Catharina Ziekenhuis
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of fluorouracil in colorectal cancer (CRC) and pancreatic cancer (PC) (3 arms), sponsored by Catharina Ziekenhuis. Planned start Mar 2019; status: not yet recruiting.
02
Drugs
fluorouracil
03
Conditions
colorectal cancer (CRC)pancreatic cancer (PC)
Beyond the preview
Go deeper on NL-OMON21471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21471.